Follow The Filings

NUTX Nutex Health

Nutex Health earnings company data as of 4:48 AM ET 10/21

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 18 Nov EPS 5.53 — —
Rev — — —

Insider trades

Open-market buys and sales by NUTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NUTX insider trades
  • $148K bought by 5 insiders
  • $43K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Scott J Saunders Director
    Sale
    $43K 203 shares at $214.25 34% of stake
    Traded Sep 18 Filed Sep 18
    ↗
  2. Warren Hosseinion President
    Buy
    $24K 252 shares at $94.07 +3.4% to stake
    Traded Mar 19 Filed Mar 23
    ↗
  3. Frank E Jaumot Director
    Buy
    $14K 150 shares at $93.56 New stake
    Traded Mar 20 Filed Mar 23
    ↗
  4. Kelvin Spears Director
    Buy
    $945 10 shares at $94.46 +<0.1% to stake
    Traded Mar 17 Filed Mar 18
    ↗
  5. Pamela W. Montgomery Chief Legal Officer-Healthcare
    Buy
    $7,021 79 shares at $88.87 +2.9% to stake
    Traded Mar 13 Filed Mar 16
    ↗
  6. Jon Christian Bates CFO
    Buy
    $103K 750 shares at $136.71 +15% to stake
    Traded Nov 25, 2025 Filed Nov 28, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 11 option exercises, 6 share withholdings for taxes, and 3 other transactions.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
8-K 1.05 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.